vs
Side-by-side financial comparison of FIRST MID BANCSHARES, INC. (FMBH) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
FIRST MID BANCSHARES, INC. is the larger business by last-quarter revenue ($88.2M vs $75.5M, roughly 1.2× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 3.4%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 5.0%).
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
FMBH vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $88.2M | $75.5M |
| Net Profit | $23.7M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 34.0% | 22.7% |
| Net Margin | 26.8% | — |
| Revenue YoY | 3.4% | 27.7% |
| Net Profit YoY | 23.5% | — |
| EPS (diluted) | $0.98 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $88.2M | $75.5M | ||
| Q3 25 | $89.3M | $54.5M | ||
| Q2 25 | $87.5M | $52.4M | ||
| Q1 25 | $84.3M | $46.0M | ||
| Q4 24 | $85.3M | $59.1M | ||
| Q3 24 | $80.6M | $80.5M | ||
| Q2 24 | $79.2M | $47.1M | ||
| Q1 24 | $79.9M | $43.8M |
| Q4 25 | $23.7M | — | ||
| Q3 25 | $22.5M | $8.8M | ||
| Q2 25 | $23.4M | $5.9M | ||
| Q1 25 | $22.2M | $3.0M | ||
| Q4 24 | $19.2M | — | ||
| Q3 24 | $19.5M | $20.3M | ||
| Q2 24 | $19.7M | $-4.5M | ||
| Q1 24 | $20.5M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 34.0% | 22.7% | ||
| Q3 25 | 32.2% | 17.6% | ||
| Q2 25 | 34.4% | 12.7% | ||
| Q1 25 | 33.4% | 8.7% | ||
| Q4 24 | 29.7% | 22.6% | ||
| Q3 24 | 31.5% | 27.4% | ||
| Q2 24 | 33.7% | -4.6% | ||
| Q1 24 | 33.7% | -5.3% |
| Q4 25 | 26.8% | — | ||
| Q3 25 | 25.2% | 16.2% | ||
| Q2 25 | 26.8% | 11.2% | ||
| Q1 25 | 26.3% | 6.5% | ||
| Q4 24 | 22.5% | — | ||
| Q3 24 | 24.2% | 25.2% | ||
| Q2 24 | 24.9% | -9.6% | ||
| Q1 24 | 25.6% | -11.0% |
| Q4 25 | $0.98 | $0.26 | ||
| Q3 25 | $0.94 | $0.17 | ||
| Q2 25 | $0.98 | $0.12 | ||
| Q1 25 | $0.93 | $0.06 | ||
| Q4 24 | $0.81 | $0.40 | ||
| Q3 24 | $0.81 | $0.41 | ||
| Q2 24 | $0.82 | $-0.09 | ||
| Q1 24 | $0.86 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $354.5M | $22.7M |
| Stockholders' EquityBook value | $958.7M | $130.3M |
| Total Assets | $8.0B | $216.3M |
| Debt / EquityLower = less leverage | 0.37× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | $354.5M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $958.7M | $130.3M | ||
| Q3 25 | $932.2M | $115.3M | ||
| Q2 25 | $894.1M | $104.7M | ||
| Q1 25 | $870.9M | $97.1M | ||
| Q4 24 | $846.4M | $92.1M | ||
| Q3 24 | $858.5M | $71.1M | ||
| Q2 24 | $813.6M | $48.5M | ||
| Q1 24 | $798.0M | $51.0M |
| Q4 25 | $8.0B | $216.3M | ||
| Q3 25 | $7.8B | $202.9M | ||
| Q2 25 | $7.7B | $194.9M | ||
| Q1 25 | $7.6B | $196.2M | ||
| Q4 24 | $7.5B | $213.3M | ||
| Q3 24 | $7.6B | $220.7M | ||
| Q2 24 | $7.6B | $205.0M | ||
| Q1 24 | $7.7B | $214.1M |
| Q4 25 | 0.37× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.9M | $14.4M |
| Free Cash FlowOCF − Capex | $124.0M | $14.4M |
| FCF MarginFCF / Revenue | 140.6% | 19.1% |
| Capex IntensityCapex / Revenue | 7.8% | 0.0% |
| Cash ConversionOCF / Net Profit | 5.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $207.9M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.9M | $14.4M | ||
| Q3 25 | $33.0M | $9.7M | ||
| Q2 25 | $7.7M | $14.1M | ||
| Q1 25 | $47.9M | $3.6M | ||
| Q4 24 | $124.4M | $15.6M | ||
| Q3 24 | $33.1M | $11.0M | ||
| Q2 24 | $24.0M | $1.0M | ||
| Q1 24 | $29.0M | $11.2M |
| Q4 25 | $124.0M | $14.4M | ||
| Q3 25 | $31.9M | $9.7M | ||
| Q2 25 | $6.0M | $14.1M | ||
| Q1 25 | $46.0M | $3.6M | ||
| Q4 24 | $119.5M | $15.6M | ||
| Q3 24 | $32.0M | $11.0M | ||
| Q2 24 | $22.9M | $1.0M | ||
| Q1 24 | $27.6M | — |
| Q4 25 | 140.6% | 19.1% | ||
| Q3 25 | 35.8% | 17.7% | ||
| Q2 25 | 6.8% | 26.8% | ||
| Q1 25 | 54.5% | 7.7% | ||
| Q4 24 | 140.0% | 26.4% | ||
| Q3 24 | 39.7% | 13.7% | ||
| Q2 24 | 28.9% | 2.1% | ||
| Q1 24 | 34.5% | — |
| Q4 25 | 7.8% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 2.3% | 0.1% | ||
| Q4 24 | 5.8% | 0.0% | ||
| Q3 24 | 1.4% | 0.0% | ||
| Q2 24 | 1.4% | 0.0% | ||
| Q1 24 | 1.9% | 0.0% |
| Q4 25 | 5.53× | — | ||
| Q3 25 | 1.47× | 1.10× | ||
| Q2 25 | 0.33× | 2.41× | ||
| Q1 25 | 2.16× | 1.21× | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | 1.70× | 0.54× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
